Martin Shkreli scores $2.7 million payday

Martin Shkreli in 86 seconds

Martin Shkreli, the controversial ex-drug executive now facing federal criminal charges, nearly doubled the money he invested in KaloBios, the drug company he briefly ran last fall.

Shkreli started buying shares of KaloBios (KBIO) last November when it was a penny stock, about a month before he was arrested. At the time, the company was in bad shape, winding down operations and liquidating its assets.

Let’s block ads! (Why?)

World business news –

You May Also Like